Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$10.84 - $16.55 $271,000 - $413,750
-25,000 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$15.69 - $21.14 $376,560 - $507,360
24,000 Added 2400.0%
25,000 $17,000
Q4 2017

Jan 17, 2018

BUY
$12.85 - $18.1 $6,425 - $9,050
500 Added 100.0%
1,000 $1,000
Q3 2017

Oct 17, 2017

BUY
$15.4 - $18.85 $7,700 - $9,425
500
500 $0

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $259M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.